Laura Last, a life sciences sales and training professional for more than 20 years, has been selected to join the LTEN Board of Directors, effective immediately. Last replaces Megan Sullivan of Sobi, who resigned her seat in April due to an expanding work role.
Last is executive director of global commercial operations learning & performance for Amgen, where she’s worked since 2006. Last has also held sales, training and management positions for companies including Novartis, Sanofi-Aventis and Catalina Lifesciences.
“I’m honored to join my life sciences sales training colleagues on the LTEN Board of Directors, and I look forward to adding value to the network,” Last said. “Life sciences sales training has been my focus for the majority of my career, and it’s good to be able to give back by helping to support my industry friends, colleagues and peers.”
“Laura was a great choice to fill Megan’s seat on the board, and I know she’ll offer a valuable voice to the leadership discussions,” said Dawn Brehm, LTEN executive director. “Laura’s skills and experience will be an asset to the board, especially now, in a time when training is reinventing itself with new delivery and management needs. Laura’s work leading global training will bring perspective as we focus on reaching remote learners.”
The Life Sciences Trainers & Educators Network (www.L-TEN.org) is the only global 501(c)(3) nonprofit organization specializing in meeting the needs of life sciences learning professionals. LTEN shares the knowledge of industry leaders, provides insight into new technologies, offers innovative solutions and communities of practice that grow careers and organizational capabilities. Founded in 1971, LTEN has grown to more than 2,100 individual members who work in pharmaceutical, biotech, medical device and diagnostic companies, and industry partners who support the life sciences training departments.
For more information contact Nannette Nolan, LTEN director of marketing communications, at nnolan@L-TEN.org.